T J Cleophas1, E M de Vogel. 1. Department of Medicine, Merwede Hospital, Dordrecht, The Netherlands.
Abstract
BACKGROUND: In controlled clinical trials the new treatment may be a slight modification of the standard or be equivalent to it with the addition of a new component. In this situation there is a positive correlation between the response to the new and the standard treatment. OBJECTIVE: The influence of the correlation between the treatment responses on the statistical sensitivity of testing was studied. Randomized trials of equivalent treatments in psychiatry and hypertension research were studied for their design in relation to their level of correlation. RESULTS: With equivalent treatments and, thus, a positive correlation a paired analysis provides better power than an unpaired one. CONCLUSIONS: Crossover studies are a better format than parallel-group studies for comparing equivalent treatments. The scientific community is technically largely unaware of the mechanisms by which correlation levels influence or lack to influence the statistical power of controlled clinical trials.
BACKGROUND: In controlled clinical trials the new treatment may be a slight modification of the standard or be equivalent to it with the addition of a new component. In this situation there is a positive correlation between the response to the new and the standard treatment. OBJECTIVE: The influence of the correlation between the treatment responses on the statistical sensitivity of testing was studied. Randomized trials of equivalent treatments in psychiatry and hypertension research were studied for their design in relation to their level of correlation. RESULTS: With equivalent treatments and, thus, a positive correlation a paired analysis provides better power than an unpaired one. CONCLUSIONS: Crossover studies are a better format than parallel-group studies for comparing equivalent treatments. The scientific community is technically largely unaware of the mechanisms by which correlation levels influence or lack to influence the statistical power of controlled clinical trials.
Authors: Cleber Davi Del Rei Daltro Rosa; Rafaella de Souza Leão; Cátia Maria Fonseca Guerra; Eduardo Piza Pellizzer; Bruno Gustavo da Silva Casado; Sandra Lúcia Dantas de Moraes Journal: Saudi Dent J Date: 2021-03-14
Authors: Mônica Chassot; Jairo Alberto Dussan-Sarria; Francislea Cristina Sehn; Alícia Deitos; Andressa de Souza; Rafael Vercelino; Iraci L S Torres; Felipe Fregni; Wolnei Caumo Journal: BMC Complement Altern Med Date: 2015-05-07 Impact factor: 3.659
Authors: Osama A Abulseoud; Thomas J Ross; Hyung Wook Nam; Elisabeth C Caparelli; Michael Tennekoon; Brooke Schleyer; Juan Castillo; John Fedota; Hong Gu; Yihong Yang; Elliot Stein Journal: Neuropsychopharmacology Date: 2020-06-19 Impact factor: 7.853